Dengue Vaccine Makers Struggle to Find a Diagnostic That Will Make its Product Safe to Use

Newly published data reveal in greater depth the problem Sanofi Pasteur’s Dengvaxia vaccine poses to children who have never experienced a dengue infection. The findings, first revealed by the company last November, were the basis of an April decision by ...